September 24, 2025
Dear Potential Applicant:
You are invited to submit an application to the Pennsylvania Department of Health in accordance with
the enclosed Request for Applications (RFA) 67-205.
All questions regarding this RFA must be directed by e-mail to ra-healthresearch@pa.gov with an email
subject line of “PA DOH RFA #67-205 QUESTIONS”, no later than 12:00 p.m. ET on October 7, 2025. All
questions must include the specific section of the RFA about which the potential applicant is requesting
clarification. Answers to all questions will be posted at www.emarketplace.state.pa.us. Click on ‘Solicitations’
and search for the above RFA number.
A Letter of Intent (LOI) must be submitted by email to ra-healthresearch@pa.gov. The Letter of Intent
must be prepared using the Letter of Intent form provided in Part Two of this RFA. The Letter of Intent must
be submitted no later than 1:30 pm ET on November 3, 2025. If the Letter of Intent is not received using the
form provided on or before this date and time, the application will not be accepted. Type “LOI ENCLOSED
RFA #(67-205)” as the subject line of your e-mail submission.
Upon receipt of the Letter of Intent, the applicant will receive a link to a SharePoint site for submission of
the application. The application must be submitted through the SharePoint site link no later than 1:30 pm ET
on November 24, 2025. As the link will be removed at the submission deadline, applicants are encouraged
to not wait until this closing date and time.
LATE APPLICATIONS WILL NOT BE ACCEPTED REGARDLESS OF THE REASON.
We expect that the evaluation of applications and the selection of Grantees will be completed within six
months of the submission due date.
Enclosure
Sincerely,
Rebekah
Digitally signed by
Rebekah Gregorowicz
Gregorowicz Date: 2025.09.24 09:18:43
-04'00'
Office of Procurement
For Agency Head
Health and Human Services Building | 625 Forster Street | Harrisburg, PA 17120-0701 | www.health.pa.gov
Request for Application
Research to Cure and Prevent Type 1
(Juvenile) Diabetes
RFA Number
67-205
Date of Issuance
September 24, 2025
Issuing Office:
Pennsylvania Department of Health
Office of Procurement
Email: RA-DHHEALTH_DEPT_DOC@pa.gov
RFA Project Officer:
Sylvia Golas
Pennsylvania Department of Health
Health Research Office
Email: ra-healthresearch@pa.gov
Research to Cure and Prevent Type 1 (Juvenile) Diabetes
CONTENTS
Part One: General Information
......................................................... 1
A. Information for Applicants .................................................................................................. 2
1. Background of Funding Source ......................................................................2
2. RFA Information .............................................................................................2
3. Lead Applicant and Support ...........................................................................3
4. Requirements of the Research Project...........................................................4
5. Use of Funds – Limitations and Additional Requirements...............................4
6. Use of Existing Health Data............................................................................6
7. Effective and Termination Dates for Grant......................................................6
B. Application Procedures …………….………………………………………………………6
1. General ..........................................................................................................6
2. Evaluation of Applications ..............................................................................7
3. Awards...........................................................................................................7
4. Deliverables and Reporting Requirements .....................................................8
C.Application Instructions and Required Format...............................................................8
1. Application Instructions ..................................................................................8
2. Application Format .........................................................................................8
3. Definitions ....................................................................................................10
D. Research Information and Priority............................................................................11
Part Two: Title of Application
....................................................... 12
Application Forms and Attachments
I. Cover Page
II. BOP-2201 Worker Protection and Investment Certification Form
III. BOP-1307 Lobbying Certification Form
IV. Research Proposal (Section One) and Letters of Support (Section
Two) are downloadable and are attached for completion
V. Budget Template is downloadable and is attached for completion of
the budget request
VI. Certifications for the Protection of Human Subjects and Regarding
the Use of Human Embryonic Stem Cell Research
VII. Certifications for the Containment of Research Involving
Recombinant or Synthetic Nucleic Acid Molecules (r/sNA) and the
Care and Treatment of Vertebrate Laboratory Animals
VIII. Application to the Pennsylvania Department of Health Institutional
Review Board
IX. Memorandum of Understanding Regarding Ethical Standards
X. Letter of Intent Form
XI. Annual Expenditure Report
Any Grant Agreement resulting from this RFA will include certain standard terms
and conditions that will be attached as appendices and will be part of the
agreement, which may either be found at http://www.health.pa.gov/vendors or
are attachments to this RFA. These terms and conditions are not negotiable
and are listed below:
� Payment Provisions (Rev. 10/21)
� Program Specific Provisions
� Commonwealth Standard General Terms and Conditions (Grant) (Rev.
10/1/23)
� Department Standard General Terms and Conditions (Grant) (Rev.
12/24)
� Audit Requirements (Rev. 10/24)
� Commonwealth Travel and Subsistence Rates (Rev. 8/18)
� Federal Lobbying Certification and Disclosure (Rev. 12/05)
� Minimum Personal Computer Hardware, Software, and Peripherals
Requirements (Rev. 1/19)
� Pro-Children Act of 1994 (Rev. 12/05)
� Federal Standard Terms and Conditions (Grant) (Rev. 12/24)
PART ONE
Research to Cure and Prevent Type 1
(Juvenile) Diabetes
General Information
1
This is the opportunity summary page. It provides an overview of this opportunity and a preview of the attached documentation.